Avantor (AVTR) Expected to Release Quarterly Earnings on Wednesday

Avantor (NYSE:AVTR) will likely be posting its Q2 2026 results before the market opens on Wednesday, July 29th. Analysts expect Avantor to announce earnings of $0.19 per share and revenue of $1.6107 billion for the quarter. Interested persons may visit the the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 8:00 AM ET.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.54 billion. During the same period last year, the company earned $0.23 EPS. The business’s quarterly revenue was up .0% compared to the same quarter last year. On average, analysts expect Avantor to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Avantor Price Performance

AVTR opened at $10.97 on Wednesday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.17 and a current ratio of 1.76. The stock has a market capitalization of $7.49 billion, a PE ratio of -13.55, a price-to-earnings-growth ratio of 5.93 and a beta of 0.94. The stock’s 50 day moving average price is $9.51 and its 200-day moving average price is $9.40. Avantor has a 52-week low of $7.26 and a 52-week high of $15.93.

Insider Activity at Avantor

In other news, Director Simon Dingemans purchased 25,000 shares of Avantor stock in a transaction that occurred on Friday, May 1st. The shares were bought at an average cost of $8.14 per share, with a total value of $203,500.00. Following the completion of the purchase, the director directly owned 25,000 shares in the company, valued at approximately $203,500. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Gregory T. Lucier acquired 10,000 shares of the firm’s stock in a transaction on Friday, May 8th. The stock was purchased at an average price of $8.32 per share, with a total value of $83,200.00. Following the acquisition, the director owned 60,000 shares of the company’s stock, valued at $499,200. This represents a 20.00% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 0.28% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. EverSource Wealth Advisors LLC lifted its position in Avantor by 119.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after acquiring an additional 1,189 shares during the period. Los Angeles Capital Management LLC purchased a new stake in Avantor in the fourth quarter worth about $32,000. Strategic Wealth Investment Group LLC bought a new position in shares of Avantor during the second quarter valued at approximately $32,000. Osaic Holdings Inc. increased its stake in shares of Avantor by 60.9% during the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after purchasing an additional 1,064 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Avantor by 28.1% during the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock valued at $49,000 after purchasing an additional 905 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

AVTR has been the topic of several recent analyst reports. Sanford C. Bernstein assumed coverage on shares of Avantor in a report on Friday, June 26th. They issued a “market perform” rating and a $10.50 price target on the stock. Wall Street Zen upgraded shares of Avantor from a “hold” rating to a “buy” rating in a report on Saturday, June 27th. TD Cowen reaffirmed a “hold” rating on shares of Avantor in a research report on Wednesday, July 15th. Barclays lifted their target price on shares of Avantor from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, June 24th. Finally, UBS Group set a $8.00 price target on shares of Avantor in a research report on Wednesday, June 24th. Two research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average target price of $10.62.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.